NCT02454387View on ClinicalTrials.gov

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacology of ONO-4474 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Osteoarthritis
Interventions
DRUG

ONO-4474 Part A1

Healthy volunteers

DRUG

Placebo Part A1

Healthy volunteers

DRUG

ONO-4474 Part A2

Healthy volunteers

DRUG

Placebo Part A2

Healthy volunteers

DRUG

ONO-4474 Part B

Healthy volunteers

DRUG

Placebo Part B

Healthy volunteers

DRUG

ONO-4474 Part C

Healthy volunteers

DRUG

Placebo Part C

Healthy volunteers

DRUG

ONO-4474 Part D

Healthy volunteers

DRUG

Placebo Part D

Healthy volunteers

Trial Locations (2)

Unknown

Aalborg Clinical Site, Aalborg

Nottingham Clinical SIte, Nottingham

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY